Page 172 - TD-3-4
P. 172

Tumor Discovery                                                Signet ring cell carcinoma of the urinary bladder



            to the primary site of origin of a malignant tumor  and   manuscript have been conducted in accordance with the
                                                      2
            molecular approaches that could be useful to this goal are   Declaration of Helsinki and its later amendments.
            not always accessible, 16,17  the application of deep-learning-
            based algorithms on whole-slide histological images  is a   Consent for publication
                                                      18
            promising tool for identifying the primary site of origin of   Informed consent for the publication of data and images
            a CUP.                                             was  obtained from the  next-of-kin  as the  subject had
            4. Conclusion                                      passed away.

            Primary SRCC is a variant of adenocarcinoma that rarely   Availability of data
            develops primarily in the urinary bladder. It may manifest   All data generated or analyzed during this study are
            as a CUP, as evidenced by the case described here. The   included in the submitted article.
            prognosis of this carcinoma is typically dismal as it is an
            aggressive tumor, and the diagnosis is generally made at an   References
            advanced stage of the disease. The urinary bladder should   1.   Krämer A, Bochtler T, Pauli C, et al. Cancer of unknown
            be considered as a site of origin of SRCC when the most   primary: ESMO Clinical Practice Guideline for diagnosis,
            common sites of origin (i.e., the gastrointestinal tract) have   treatment and follow-up. Ann Oncol. 2023;34(3):228-246.
            been excluded, even in the absence of an endoluminal mass
            and with negative urinary cytology results, as observed in      doi: 10.1016/j.annonc.2022.11.013
            the case reported here. We believe that our case may have   2.   Levi F, Te VC, Erler G, Randimbison L, La Vecchia C.
            significant implications in clinical practice. It is imperative   Epidemiology of unknown primary tumours. Eur J Cancer.
            that clinicians are aware of the possibility of a metastatic   2002;38(13):1810-1812.
            SRCC originating from the urinary bladder.            doi: 10.1016/s0959-8049(02)00135-1
            Acknowledgments                                    3.   Massard C, Loriot Y, Fizazi K. Carcinomas of an unknown
                                                                  primary  origin--diagnosis  and  treatment.  Nat Rev  Clin
            None.                                                 Oncol. 2011;8(12):701-710.

            Funding                                               doi: 10.1038/nrclinonc.2011.158
                                                               4.   Pavlidis N, Fizazi K. Carcinoma of unknown primary
            None.                                                 (CUP). Crit Rev Oncol Hematol. 2009;69(3):271-278.

            Conflict of interest                                  doi: 10.1016/j.critrevonc.2008.09.005
            The authors declare that they have no competing interests.  5.   Oien KA. Pathologic evaluation of unknown primary
                                                                  cancer. Semin Oncol. 2009;36(1):8-37.
            Author contributions                                  doi: 10.1053/j.seminoncol.2008.10.009
            Conceptualization:  Emma Rullo, Mara Riminucci,    6.   Beauchamp K,  Moran B, O’Brien T,  et al. Carcinoma of
               Alessandro Corsi, Salvatore Minisola               unknown primary (CUP): An update for histopathologists.
            Formal analysis:  Emma Rullo, Piergianni Biondi, Chiara   Cancer Metastasis Rev. 2023;42:1189-1200.
               Nicolazzo, Walter Gianni, Luciano Colangelo, Mirella      doi: 10.1007/s10555-023-10101-6
               Cilli, Paola Gazzaniga, Mara Riminucci, Alessandro
               Corsi                                           7.   Celik O, Budak S, Ekin G, Akarken I, Ilbey YO. A  case
            Methodology:  Emma Rullo, Chiara Nicolazzo, Paola     with primary signet ring cell adenocarcinoma of the
                                                                  prostate and review of the literature. Arch Ital Urol Androl.
               Gazzaniga, Mara Riminucci, Alessandro Corsi        2014;86(2):148-149.
            Investigation:  Emma Rullo, Chiara Nicolazzo, Paola
               Gazzaniga, Mara Riminucci, Alessandro Corsi,       doi: 10.4081/aiua.2014.2.148
               Salvatore Minisola                              8.   Lendorf  ME, Dohn  LH, Dunga BA, Loya  AC, Pappot  H.
            Writing–original draft: Emma Rullo                    An updated review on primary signet-ring cell carcinoma
            Writing–review & editing: Emma Rullo, Mara Riminucci,   of the urinary bladder and report of a case. Scand J Urol.
               Alessandro Corsi, Salvatore Minisola               2018;52(2):87-93.
                                                                  doi: 10.1080/21681805.2017.1418020
            Ethics approval and consent to participate
                                                               9.   Benerjee N, Parmar K, Vaiphei K. Primary signet-ring
            Ethical approval is not required as this is a case report. All   cell carcinoma of the urinary bladder.  Autops Case
            the clinical and pathologic investigations detailed in the   Rep. 2021;11:e2021264.


            Volume 3 Issue 4 (2024)                         4                                 doi: 10.36922/td.3736
   167   168   169   170   171   172   173   174   175   176   177